Tweet
Hello,
I am advising a large university in an oil-rich country that wants to set up a second-generation sequencing centre. There are already established molecular biology labs there, but the sequencing expertise is limited (no really large-scale Sanger sequencing done) although they consider that there are a lot of interesting organisms to be sequenced locally. So they do not plan to set up the centre by themselves, instead they are considering a contract with a reputable, well-established service sequencing firm already using 2nd generation systems. Such a company would set up and man a sequencing centre in their university, while they would essentially provide the capital investment and the customers. Many details need to be worked out, but this is the general scheme. It is important for them that the actual location of the sequencing system (probably a 454 type given that much of the work would be de novo sequencing) be in their country, even if this may not be the most sensible initial option in terms of economics. A European company would probably be preferred, but other origins are possible.
I am planning to contact a number of sequencing companies that I know of, but am also posting this message so that interested parties can contact me. Please note that I am only interested in direct contact with sequencing companies, not in any intermediates! (I am a semi-retired academic with experience in molecular biology, genetics & genomics, and an advisor to several biotech companies).
Best wishes to all
Bertrand Jordan
I am advising a large university in an oil-rich country that wants to set up a second-generation sequencing centre. There are already established molecular biology labs there, but the sequencing expertise is limited (no really large-scale Sanger sequencing done) although they consider that there are a lot of interesting organisms to be sequenced locally. So they do not plan to set up the centre by themselves, instead they are considering a contract with a reputable, well-established service sequencing firm already using 2nd generation systems. Such a company would set up and man a sequencing centre in their university, while they would essentially provide the capital investment and the customers. Many details need to be worked out, but this is the general scheme. It is important for them that the actual location of the sequencing system (probably a 454 type given that much of the work would be de novo sequencing) be in their country, even if this may not be the most sensible initial option in terms of economics. A European company would probably be preferred, but other origins are possible.
I am planning to contact a number of sequencing companies that I know of, but am also posting this message so that interested parties can contact me. Please note that I am only interested in direct contact with sequencing companies, not in any intermediates! (I am a semi-retired academic with experience in molecular biology, genetics & genomics, and an advisor to several biotech companies).
Best wishes to all
Bertrand Jordan